藥物成份

共有 21663 個藥物成份

Bovine Serum Albumin, Goat-anti-(Rabbit IgG) Polyclonal Antibody, Murine Anti a-hCG Polylonal Antibody, Murine Anti-B-hCG Monoclonal Antibody Colloidal Gold Conjugate, Rabbit IgG-Colloidal Gold Conjugate, Sodium Azide, Sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin, Goat-anti-Rabbit Antibody, Opiate-BSA Conjugate, Mouse Anti-Opiate Antibody, Rabbit IgG-Colloidal Gold Conjugate, Sodium Azide, sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin,Goat-anti-(Rabbit IgG) Polyclonal Antibody, Murine Anti-LH Monoclonal Antibody Colloidal Gold Conjugate, Rabbit IgG-Colloidal Gold Conjugate, Murine Anti-LH Antibody, Sodium Azide, Sodium Dibasic Phosphate, Sodium Chloride.

• 關聯藥證數量: 1

Bovine Serum Albumin\nCarbamazepine\nPhenobarbital\nPhenytoin\nTheophylline\nValproic Acid

• 關聯藥證數量: 1

Bovine Thrombin 100NIH (#50502:10 x 2 mL or #50555: 10 x 5 mL), \nImidazole Buffered saline (#50504: 2 x 135 mL)\nNormal coagulation Control (#50100: 10 x 1 mL)\nHemostasis Reference Plasma, Abnormal (#50721: 10 x 1 mL)

• 關聯藥證數量: 1

Bovine serum albumin

• 關聯藥證數量: 1

Bovine serum albumin suitable quantity ; Each analytes suitable quantity

• 關聯藥證數量: 1

Bovine serum albumin with analyte CK-MM (human) and CK-BB (Porcine brain).

• 關聯藥證數量: 1

Bovine serum albumin, goat-anti-rabbit antibody, methamphetamine-BSA conjugate, mouse anti-methamphetamine antibody, rabbit IgG-colloidal gold conjugate, sodium azide, sodium dibasic phosphate, sodium chloride

• 關聯藥證數量: 1

Bovine serum with non-protein constituents added. Bacteriostatic agents have been added.

• 關聯藥證數量: 1

Bovine serum, analytes and preservative 3.0mL/vial

• 關聯藥證數量: 1

Brentuximab vedotin

• 關聯藥證數量: 1

Brimonidine Tartrate contains not less than 99.0% and not more than 101.0% of C11H10BrN5‧C4H6O6, calculated on dried substance.

• 關聯藥證數量: 1

Brimonidine Tartrate contains not less than 99.0% and not more than 101.0% of C15H16BrN5O6, calculated on the dried substance.

• 關聯藥證數量: 1

Brimonidine Tartrate contains not less than 99.0% and not more than 101.0% of C15H16BrN5O6, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Brinzolamide Assay (HPLC, wt%): 98.0%~102.0% on the dried basis

• 關聯藥證數量: 1

Brolucizumab

• 關聯藥證數量: 1

Brom Cresol Purple 0.005 g 溶於純水 1 mL Decarboxylase.Base Moeli 10.5g Brom Cresol Purple Solution 1 mL Argining 10 g 純水 1000 mL

• 關聯藥證數量: 1

Bromazepam contains not less than 98.9% and not more than 101.0% of C14H10BrN3O, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bromazepam contains not less than 99.0% and not more than the equivalent of 101.0% of C14H10BrN3O, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Bromcresol Green 0.27mmol/L\nTRIS 55mmol/L\nSuccinic Acid 100mmol/L\nThimerosal 0.250g/L

• 關聯藥證數量: 1

Bromcresol Green (BCG) 0.25 mM, buffer pH 4.0 ± 0.1, surfactant, non-reactive ingredients and stabilizers.\nStandard: Bovine Albumin Fraction V with stabilizer

• 關聯藥證數量: 1

Bromcresol Purple 0.28mmol/L

• 關聯藥證數量: 1

Bromcresol green (BCG) 0.26 mmol/L\nSuccinic acid 90.0 mmol/L\nBuffer, pH 4.2

• 關聯藥證數量: 1

Bromcresol purple 16 g 純水 900 mL 醣類 10 g (溶於100 mL 純水中)

• 關聯藥證數量: 1

Bromcresol purple 0.35 mmol/L

• 關聯藥證數量: 1

Bromelain contains not less than 600 CDU/mg.

• 關聯藥證數量: 1

Bromisoval,when dried,contains not less than 98.0% of C6H11BrN2O2.

• 關聯藥證數量: 1

Bromocresol green (BCG) 0.115 mmol/L\nCitrate buffer 94 mmol/L

• 關聯藥證數量: 1

Bromocresol green (BCG) 0.2 mmol/L

• 關聯藥證數量: 1

Bromocresol green(BCG) 0.3mmol/L

• 關聯藥證數量: 1

Bromovalerylurea contains not less than 98.0% of Bromovalerylurea (C6H11BrN2O2) Calculated with reference to the stated amount of the dried substance.

• 關聯藥證數量: 1

Brompheniramine maleate contains not less than 98.0% and not more than 100.5% of C16H19BrN2-C4H4O4.

• 關聯藥證數量: 1

Brotizolam contains not less than 99.0% and not more than 101.0% of C15H10BrClN4S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Brucella Agar 43 g 純水 950 mL Kanamycin 0.096 g Vancomycin 0.0075 g K1 (1%) 1 mL 冷凍綿羊血 50 mL

• 關聯藥證數量: 1

Brucella Agar 4.5 g\nAgar 13.5 g\nPeptone 9 g\nTryptone 10 g\nYeast Extract 1.5 g\nNaCl 4.5 g\nSodium Bisulfate 0.1 g\nHemin(1%) 0.25 g\n純水 950 mL\nK1 0.1 mL\n綿羊血 50 mL

• 關聯藥證數量: 1

Btm Smartest 2808 及 2818 血糖測試系統套組：包含血糖測試儀，試紙，控制液，採血筆，採血針等。\nBtm Smartest 2808 及 2818 血糖測試儀：用Bio sensor的技術測量血糖。\n控制液：中間濃度控制液(0.12% D-glucose) 高濃度控制液(0.24% D-glucose)。\nBtm Smartest 試紙是搭配Btm Smartest 血糖儀使用，以測試血液中的血糖值。

• 關聯藥證數量: 1

Buclizine Hydrochloride contains not less than 99.0 % and not more than 100.5 % of C28H33ClN2‧2HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Buclizine Hydrochloride contains not less than 99.0% and not more than 100.5% of C28H33CLN2,2HCL, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Buclizine Hydrochloride contains not less than 99.0% and not more than 100.5% of C28H33ClN2‧2HCl calculated on the dried basis.

• 關聯藥證數量: 1

Budesonide (micronized) contains not less than 98.0 % and not more than 102.0 % of C25H34O6, calculated on the dried basis.

• 關聯藥證數量: 1

Budesonide contains 97.5% to 102.0% of C25H34O6, calculated on anhydrous substance.

• 關聯藥證數量: 1

Budesonide contains not less than 97.5% and not more than 102.0% of C25H34O6, calculated on the dried basis.

• 關聯藥證數量: 1

Budesonide contains not less than 98.0% and not more than 102% of C25H34O6, calculated on the dried basis.

• 關聯藥證數量: 1

Budesonide is a mixture of two epimeric forms, epimer A (C-22S) and epimer B (C-22R).\nIt contains not less than 40.0% and not more than 51.0% of epimer A, and sum of both epimers is not less than 98.0% and not more than 102.0% of C25H34O6, calculated on the dried basis.

• 關聯藥證數量: 1

Buffer 37.6 mmol/L\nATP 2.1 mmol/L\nNAD 2.5 mmol/L\nHexokinase >1500 U/L\nG-6-PDH >2500 U/L\n

• 關聯藥證數量: 1

Buffer 37.6 mmol/L\nATP 2.1 mmol/L\nNAD 2.5 mmol/L\nHexokinase (Recombinant Yeast) >1500 U/L\nG-6-PDH (Recombinant Leuconostoc) >2500 U/L\nPH 7.7 at 20°C\n

• 關聯藥證數量: 1

Buffer (R1) Substrate Reagent (R2) 19.76 mg/ml of p-nitrophenyl disodium phosphate

• 關聯藥證數量: 1

Buffer 2.3 %

• 關聯藥證數量: 1

Buffer MES/BES (pH 6.8) 27 mmol/l; 1,2-Diglyceride substrate 0.04 mmol/l\nMonoglyceride lipase> 400 U/l; Glycerol kinase> 100 U/l\nPOD> 500 U/l; 4-Aminophenazone 0.25 mmol/l\nTAPS (pH 8.7) 50 mmol/l; TOOS 1.0 mol/l\nCo-lipase>15 kU/l; GPO>15 kU/l; ATP>0.85mol/l; Preservative\nCalibrator: Human serum containing porcine lipase.\n

• 關聯藥證數量: 1

Buffer Reagent (A)：Contains Tris buffer with sodium azide as a preservative.\nEnzyme Reagent (E)：Contains alcohol dehydrogenase (ADH) and NAD in Phosphate buffer with stabilizer and sodium azide as a preservative.\nControl：ethyl alcohol in Tris buffer with sodium azide as a preservative.\ncalibrator：Tris buffer with sodium azide as a preservative.

• 關聯藥證數量: 1

Buffer Reagent: Tris (hydroxymethyl) aminomethane 3 x 18 mlAntiserum Reagent: Anti-human haptoglobin goat antiserum 2 x 7 ml

• 關聯藥證數量: 1

Buffer Solution (Liquid): 5.6 mL x 2 vialsSubstrate (Lyophilized): 5.6 mL x 4 vialsContains 10 mmol/L of P-hydroxybenzoyl-glycine-L-histidyl-L-leucine, 2.5 mmol/L of 4-aminoantipyrine and 3 IU/mL hippuricase when reconstituted.Stopper Solution (Liquid): 15.5 mL x 4 vialsDeveloper (Lyophilized): 15.5 mL x 4 vialsContains 6.5 mmol/L of metaperiodate (NaIO4) when reconstituted.Buffer Solution for Blank (Liquid): 5.6 mL x 2 vialsContains EDTA-2Na (10 mmol/L)

• 關聯藥證數量: 1

Buffer Solution: Tris buffer (pH 7.2) 100 mmol/L\n MACROGOL 4000\nAntibody: antihuman apolipoprotein A-I polyclonal antibody (from goat), 10 U/ml.

• 關聯藥證數量: 1

Buffer pH 7.0\n4-Aminoantipyrine 1 mmol/L\nphenol 10 mmol/L\nglucose oxidase 36000 U/L\nperoxidase 12000 U/L

• 關聯藥證數量: 1

Buffer solution (R-1)\nLatex suspension (R-2)：latex particles coated with anti-human myoglobin polyclonal antibodies (rabbit)

• 關聯藥證數量: 1

Buffer solution (R-1)：Glycine buffer solution\nLatex suspension(R-2)：0.12 w/v % suspension of latex particles coated with anti-Mb antibodies.\nCalibrators：prepared by dilution of purified human myoglobin (Mb).

• 關聯藥證數量: 1

Buffer, Hemolysing solution, Wash solution, Dilution segments, Filters Capiclean.

• 關聯藥證數量: 1

Buffer, Hemolysing solution, Wash solution, Reagent cups, Filters, Bins for used cups, Lids for bins for used cups, Hemolysing solution bar code labels

• 關聯藥證數量: 1

Buffer/Substrate:\nTRIS buffer (pH 7.4) 50 mmol/l\nPyruvate 1.5 mmol/l\nSubstrate:\nNADH 0.8 mmol/l

• 關聯藥證數量: 1

Buffer: 100mmol/L Tris buffer (pH8.5) MACROGOL Antibody: Antihuman apolipoprotein A-II polyclonal antibody (from goat): 10U/mL

• 關聯藥證數量: 1

Buffer: Citrate buffer, pH 2.9, Surfactant\nVanadate: Phosphate buffer, pH 7.0, Sodium metavanadate\n

• 關聯藥證數量: 1

Buffer: Tris-Buffer \nEnzyme Reagent: Urease, GLDH, NADH, Adenosine-5-diphosphate, a-oxoglutarate\nStandard

• 關聯藥證數量: 1

Buffer: sodium chloride, methylamine and surfactant.\nPlasmin reagent: human plasmin, buffer, human serum albumin, stabilizers and bulking agent.\nChromogenic substrate: the lyophilized chromogenic substrate, pyroGlu-Phe-Lys-pNA.HCl and bulking agent.\n

• 關聯藥證數量: 1

Buffer:\nAcetate Buffer 0.2 mmol/l, pH 4.7\nNon reactive stabilizers\nChromogen:\nAcetate Buffer 0.2 mmol/l, pH 4.7\nComplexant 3,5-Di-Br-PAESA\nReagent:\nAscorbic Acid

• 關聯藥證數量: 1

Buffer:\nDiethanolamine buffer (pH 10.35 + 0.2) 1.25mol/l\nMagnesium chloride 0.625 mmol/l\nSubstrate:\np-Nitrophenyl phosphate 55 mmol/l

• 關聯藥證數量: 1

Buffer\nGlycine Buffer 170 mmol/l, pH8.3\nSodium chloride 100 mmol/l\nLatex Reagent\nGlycine Buffer 170 mmol/l, pH 7.3\nSodium chloride 100 mmol/l\nLatex particles coated with Anti-Ferritin 0.07% w/v

• 關聯藥證數量: 1

Buffered alcohol-based liquid

• 關聯藥證數量: 1

Buffered blcarbonate and electrolyte solution equilibrated with precise mixtures of O2,CO2,and N2 gases.

• 關聯藥證數量: 1

Buffered formaldehyde 10% v/v:\nWater、\nFormaldehyde 10% v/v、\nInorganic buffer、\nBuffered formaldehyde 19% w/v:\nWater、\nFormaldehyde 19% w/v、\nInorganic buffer \n

• 關聯藥證數量: 1

Buffered liquid solution containing 1.5% formaldehyde.

• 關聯藥證數量: 1

Buffered qeuine serum matrix, preservative.

• 關聯藥證數量: 1

Buffered solution of electrolytes (Na+, K+, Cl-, Li+, Ca++, HCO3-/CO32-) It has been equilibrated with specific levels of CO2, O2, and N2

• 關聯藥證數量: 1

Buffered solution of pH7.35

• 關聯藥證數量: 1

Buffer： TAPS(a) 100mM\n Sodium hydroxide 40mM\n Sodium deoxycholate 34mM\n Sodium azide 7.7mM\nSubstrate：(+)-Tartaric acid 9.5mM\n Sodium hydroxide 19mM\nColipase 460IU/ml\n2-Propanol 0.65M\nDGGMR(b) 0.4mM\n

• 關聯藥證數量: 1

Buffer：2-(Ethylamino) ethanol (EAE) buffer, pH9.9；Magnesium chloride

• 關聯藥證數量: 1

Buffer：Good’s buffer, pH 6.4

• 關聯藥證數量: 1

Buffer：Good’s buffer, pH 7.7\nLatex reagent：latex sensitized with human gammaglobulin\nRF LT calibrator：Rheumatoid factor from human sera

• 關聯藥證數量: 1

Buflomedil Hydrochloride contains not less than 98.5% and not more than 101.5%(dried substance).

• 關聯藥證數量: 1

Bumetanide contains not less than 99.0% and not more than 101.0% of C17H20N2O5S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Buprenorphine HCL contains 98.5 % to 101.5 % (dried substance).

• 關聯藥證數量: 1

Buprenorphine Hydrochloride Content: 98.5 percent to 101.5 percent (dried substance)

• 關聯藥證數量: 1

Buprenorphine Hydrochloride contains not less than 98.5% and not more than 101.5 % of C29H42ClNO4, calculated on the dried substance.

• 關聯藥證數量: 1

Bupropion Hydrochloride contains not less than 98% and not more than 102.0% of C13H18ClNO.HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bupropion Hydrochloride contains not less than 98.0% and not more than 102.0% of C13H18ClNO.HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bupropion Hydrochloride contains not less than 98.0% and not more than 102.0% of C13H18ClNO‧HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bupropion Hydrochloride contains not less than 98.0% and not more than 102.0% of C13H19Cl2NO, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Bupropion hydrochloride contains not less than 98.0% and not more than 102.0% of C13H18ClNO．HCl, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Butamirate Citrate contains 98.5% ~ 101.0% of C24H37BrNO10, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Butamirate Citrate contains not less than 98% and not more than 101% of C18H29NO3* C6H8O7

• 關聯藥證數量: 1

Butamirate Citrate contains not less than 98.5% and not more than 101.0% of C24H37NO10, calculated on the dried substance.

• 關聯藥證數量: 1

Butenafine Hydrochloride Butenafine Hydrochloride contains not less than 99.0% and not more than 101.0% of C23H27N‧HCl, calculated on the dried substance.

• 關聯藥證數量: 1

Butyl-P-Hydroxybenzoate

• 關聯藥證數量: 1

Butylated

• 關聯藥證數量: 1

B：Sample Diluent\nC：Sensitized Particles\nD：Unsensitized Particles\nE：Positive Control

• 關聯藥證數量: 1

B：Serum Diluent(Liquid)\nPhosphate buffer saline containing normal rabbit sera and 0.1% sodium azide.\nC：Antibody-Sensitized Cells(Lyophilized)\nLyophilized preparation of fixed chicken erythrocytes sensitized with anti-AFP mouse antibody. The reconstituted reagent includes 0.66% anti-AFP Antibody-Sensitized Cells.\nD：Control Cells(Lyophilized)\nLyophilized preparation of fixed chicken erythrocytes sensitized with mouse IgG.\nE：Positive Control(Liquid)\n1：10 diluted preparation of human serum positive for AFP with Serum Diluent. The control include gives a 1：320 end point titer at final dilution when tested according to the Positive Control Test Procedure\nF：Absorbent Cells (Lyophilized)\nLyophilized preparation of chicken erythrocytes sensitized with mouse IgG..\n

• 關聯藥證數量: 1

B？R？A？H？M？S SCC KRYPTOR\nCRYPTATE CONJUGATE:\nAnti-SCC monoclonal mouse antibody conjugated with europium cryptate, buffer, bovine albumin, bovine gammaglobulins, unspecific mouse immunoglobulins

• 關聯藥證數量: 1

C R P latex 1 (Buffer Solution)：Tris(hydroxymethyl)aminomethane(pH8.5)：20 mmol/L\nC R P latex 2 (Latex Reagent)：antihuman CRP mouse monoclonal antibody-coated latex 2.25 mg/mL\nCRP Calibrator (SS Type)：contains Serum, Azide 0.1% or less,5 vials of 2.0 mL(5 concentrations)

• 關聯藥證數量: 1

C R P(1): Tris(hydroxymethyl)aminomethane(pH8.5).\nC R P(2): antihuman CRP mouse monoclonal antibody-coated latex 2mg/mL.\nCRP Calibrator A, B, C, D: Serum.

• 關聯藥證數量: 1

C-14 UREA

• 關聯藥證數量: 1